JP Morgan Chase
SIOX

JP Morgan Chase’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

JP Morgan Chase’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,015
Closed -$2K – 7134
2021
Q3 		$2K Sell
1,015
-4,071
-80% -$8.85K ﹤0.01% 6356
2021
Q2 		$14K Buy
+5,086
New +$12.6K ﹤0.01% 5993
2020
Q3 		– Sell
-9,329
Closed -$26K – 5895
2020
Q2 		$26K Buy
9,329
+3,920
+72% +$12.6K ﹤0.01% 4993
2020
Q1 		$13K Buy
5,409
+4,695
+658% +$16.9K ﹤0.01% 5023
2019
Q4 		$4K Buy
+714
New +$3.96K ﹤0.01% 5501
2019
Q1 		– Sell
-1,578
Closed -$13K – 6128
2018
Q4 		$13K Sell
1,578
-779
-33% -$11.2K ﹤0.01% 5402
2018
Q3 		$46K Buy
+2,357
New +$42.9K ﹤0.01% 5229
2018
Q2 		– Sell
-22,903
Closed -$244K – 5750
2018
Q1 		$244K Buy
22,903
+22,028
+2,517% +$354K ﹤0.01% 4299
2017
Q4 		$37K Sell
875
-64,910
-99% -$2.91M ﹤0.01% 4990
2017
Q3 		$3.55M Sell
65,785
-49,671
-43% -$8.38M ﹤0.01% 2806
2017
Q2 		$21.4M Buy
115,456
+54,328
+89% +$9.52M ﹤0.01% 1400
2017
Q1 		$7.31M Buy
61,128
+2,391
+4% +$251K ﹤0.01% 2154
2016
Q4 		$5.84M Sell
58,737
-1,353
-2% -$142K ﹤0.01% 2326
2016
Q3 		$6.73M Sell
60,090
-49,241
-45% -$5.91M ﹤0.01% 2039
2016
Q2 		$11.2M Sell
109,331
-2,456
-2% -$245K ﹤0.01% 1758
2016
Q1 		$10.3M Sell
111,787
-943
-0.8% -$101K ﹤0.01% 1754
2015
Q4 		$16.3M Buy
112,730
+44,425
+65% +$5.78M ﹤0.01% 1488
2015
Q3 		$7.06M Buy
68,305
+15,940
+30% +$1.87M ﹤0.01% 2002
2015
Q2 		$8.54M Buy
+52,365
New +$8.88M ﹤0.01% 2034

Other funds holding SIOX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase's SIOX Position: Q4 2021 in Review

JP Morgan Chase sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2021, closing a stake of 1,015 shares — an estimated $2K sold.

JP Morgan Chase first reported a position in SIOX in Q2 2015 and held it in 19 quarters. The position peaked at $21.4M in Q2 2017. 48 funds tracked by Wall St. Rank hold SIOX as of Q4 2021.

  • JP Morgan Chase reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • JP Morgan Chase sold 1,015 Sio Gene Therapies Inc. Common Stock shares in Q4 2021, an estimated $2K.
  • JP Morgan Chase first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2015 and held it in 19 quarters.
  • JP Morgan Chase's Sio Gene Therapies Inc. Common Stock position peaked at $21.4M in Q2 2017.
  • 48 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2021.

Based on JP Morgan Chase's 13F filing for Q4 2021, filed 10 Feb 2022.